For
p
atients
For
r
esearch sites
Find a trial
Researchers
Sponsors
Patients
Company
Log in
Get started
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule